Patents-Review.com
ClassID:

170891 ⎘

G01N2800/42 - CPC Classification

Classification description:

Detection or diagnosis of diseases Poisoning, e.g. from bites or stings

Recent Application in this class:
#1
20240316168
2024-09-26

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

 #2
20240287119
2024-08-29

3-PHENOXYBENZOIC ACID-GLUCURONIC ACID CONJUGATE, AND PREPARATION METHOD AND USE THEREOF

 #3
20230092234
2023-03-23

Marker polypeptide of bothrops atrox-like thrombin and method thereof for detecting species source and content of snake venom-like thrombin and application

 #4
20220276265
2022-09-01

Methods for identifying risk of chemotherapy-induced cardiotoxicity and targeted medical intervention

 #5
20210353727
2021-11-18

IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY

 #6
20210310042
2021-10-07

SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT

 #7
20200241019
2020-07-30

Methods for Identifying Risk of Chemotherapy-Induced Cardiotoxicity and Targeted Medical Intervention

 #8
20200191774
2020-06-18

Determining toxicity risk in CAR T-cell therapy

 #9
20200102552
2020-04-02

Platform and method for identifying past exposure to chemical agents or heavy metals

 #10
20190336592
2019-11-07

OmpA and Asp14 in vaccine compositions and as diagnostic targets

 #11
20190234946
2019-08-01

OmpA in vaccine compositions and as diagnostic targets

 #12
20190151277
2019-05-23

USES OF BIOACTIVE LIPIDS

 #13
20180264097
2018-09-20

OmpA and ASP14 in vaccine compositions and as diagnostic targets

 #14
20180172710
2018-06-21

Methods and devices for rapid assessment of severity of injury

 #15
20180127472
2018-05-10

METHOD OF INHIBITING C5 CLEAVAGE

 #16
20180003726
2018-01-04

Diagnosis of leukocyte-mediated disease and halogen gas exposure

 #17
20170281738
2017-10-05

Compositions and methods relating to argininosuccinate synthetase

 #18
20170269080
2017-09-21

OmpA in vaccine compositions and as diagnostic targets

 #19
20170101441
2017-04-13

Chemical and biochemical adducts as biomarkers for organophosphate exposure

 #20
20170058275
2017-03-02

Platform and method for identifying past exposure to chemical agents or heavy metals

 #21
20160361397
2016-12-15

Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity

 #22
20160146811
2016-05-26

OMPA AND ASP14 IN VACCINE COMPOSITIONS AND AS DIAGNOSTIC TARGETS

 #23
20160096870
2016-04-07

Method of inhibiting C5 cleavage

 #24
20150323552
2015-11-12

Methods and devices for rapid assessment of severity of injury

 #25
20140178351
2014-06-26

Compositions and methods relating to argininosucccinate synthetase

 #26
20120251542
2012-10-04

Ricin ribosome binding protein compositions and methods of use thereof

 #27
20110263482
2011-10-27

Complement inhibitors

 #28
20110236931
2011-09-29

Chemical and biochemical adducts as biomarkers for organophosphate exposure

 #29
20100196938
2010-08-05

Immunoassay for venom detection including noninvasive sample collection

 #30
20090286263
2009-11-19

SKIN TAPE STRIPPING: A NON-INVASIVE DIAGNOSTIC STRATEGY FOR DERMAL EXPOSURE TO CYTOTOXIC COMPOUNDS

 #31
20090197280
2009-08-06

Methods and Devices for Rapid Assessment of Severity of Injury

 #32
20080176266
2008-07-24

Biomarkers Of Metabolic Responses To Hepatotoxicants And Carcinogens

 #33
20070141626
2007-06-21

Immunoassay for venom detection including noninvasive sample collection

 #34
20070141573
2007-06-21

Complement inhibitors

 #35
20060194267
2006-08-31

Methods and kit for diagnosing tick borne illnesses

 #36
20060078551
2006-04-13

Therapeutic and prophylactic agents and methods of using the same